Guidelines for Radioiodinated MIBG Scintigraphy in Children

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2003 Mar 27

PMID 12658506

Citations 22

Authors

Pierre Olivier

Paula Colarinha

Jure Fettich

Sibylle Fischer

Jorgen Frokier

Francesco Giammarile

Isky Gordon

Klaus Hahn

Levent Kabasakal

Mike Mann

Mercedes Mitjavila

Amy Piepsz

Ute Porn

Rune Sixt

Jeannette van Velzen

Affiliations

Soon will be listed here.

Abstract

These guidelines on the use of radioiodinated (99m)Tc-MIBG scintigraphy in children, which summarise the views of the Paediatric Committee of the European Association of Nuclear Medicine, provide a framework which may prove helpful to nuclear medicine teams in daily practice. They have been influenced by the conclusions of the "Consensus Guidelines for MIBG Scintigraphy" (Paris, November 6, 1997) of the European Neuroblastoma Group and by those of the Oncological Committee of the French Society of Nuclear Medicine. The guidelines should be taken in the context of "good practice" and any local/national rules which apply to nuclear medicine examinations.

Citing Articles

Predicting event-free survival after induction of remission in high-risk pediatric neuroblastoma: combining I-MIBG SPECT-CT radiomics and clinical factors.

Feng L, Yang X, Wang C, Zhang H, Wang W, Yang J Pediatr Radiol. 2024; 54(5):805-819.

PMID: 38492045 DOI: 10.1007/s00247-024-05901-z.

Evaluation of iodine-123-labeled metaiodobenzylguanidine single-photon emission computed tomography/computed tomography based on the International Society of Pediatric Oncology Europe Neuroblastoma score in children with neuroblastoma.

Zhou Z, Wang G, Qian L, Liu J, Yang X, Zhang S Quant Imaging Med Surg. 2023; 13(6):3841-3851.

PMID: 37284114 PMC: 10240022. DOI: 10.21037/qims-22-1120.

Imaging of pediatric neuroblastoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.

Lai H, Sharp S, Bhatia A, Dietz K, McCarville B, Rajderkar D Pediatr Blood Cancer. 2022; 70 Suppl 4:e29974.

PMID: 36184716 PMC: 10680359. DOI: 10.1002/pbc.29974.

Prevalence and Clinical Correlations of Somatostatin Receptor-2 (SSTR2) Expression in Neuroblastoma.

Alexander N, Marrano P, Thorner P, Naranjo A, Van Ryn C, Martinez D J Pediatr Hematol Oncol. 2018; 41(3):222-227.

PMID: 30334904 PMC: 6600817. DOI: 10.1097/MPH.0000000000001326.

Guidelines on nuclear medicine imaging in neuroblastoma.

Bar-Sever Z, Biassoni L, Shulkin B, Kong G, Hofman M, Lopci E Eur J Nucl Med Mol Imaging. 2018; 45(11):2009-2024.

PMID: 29938300 DOI: 10.1007/s00259-018-4070-8.

References

Wilson L, Draper G . Neuroblastoma, its natural history and prognosis: a study of 487 cases. Br Med J. 1974; 3(5926):301-7. PMC: 1611711. DOI: 10.1136/bmj.3.5926.301. View

Jacobs A, Delree M, Desprechins B, Otten J, Ferster A, JONCKHEER M . Consolidating the role of *I-MIBG-scintigraphy in childhood neuroblastoma: five years of clinical experience. Pediatr Radiol. 1990; 20(3):157-9. DOI: 10.1007/BF02012960. View

Shapiro B, Copp J, Sisson J, Eyre P, Wallis J, BEIERWALTES W . Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med. 1985; 26(6):576-85. View

Sisson J, Shulkin B . Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med. 1999; 43(3):217-23. View

Rufini V, Fisher G, Shulkin B, Sisson J, Shapiro B . Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging. J Nucl Med. 1996; 37(9):1464-8. View

Perel Y, Conway J, Kletzel M, Goldman J, Weiss S, Feyler A . Clinical impact and prognostic value of metaiodobenzylguanidine imaging in children with metastatic neuroblastoma. J Pediatr Hematol Oncol. 1999; 21(1):13-8. DOI: 10.1097/00043426-199901000-00004. View

Rufini V, Giordano A, Di Giuda D, Petrone A, Deb G, De Sio L . [123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging. Q J Nucl Med. 1995; 39(4 Suppl 1):25-8. View

Khafagi F, Shapiro B, Fischer M, Sisson J, Hutchinson R, BEIERWALTES W . Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine. Eur J Nucl Med. 1991; 18(3):191-8. DOI: 10.1007/BF02262730. View

Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I . A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine. Eur J Nucl Med. 1990; 17(3-4):127-9. DOI: 10.1007/BF00811439. View

10.

Gelfand M, Elgazzar A, Kriss V, Masters P, Golsch G . Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors. J Nucl Med. 1994; 35(11):1753-7. View

11.

Lumbroso J, Hartmann O, Schlumberger M . Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Société Française d'Oncologie Pédiatrique" and Nuclear Medicine Co-investigators. J Nucl Biol Med (1991). 1991; 35(4):220-3. View

12.

Mairs R . Neuroblastoma therapy using radiolabelled [131I]meta-iodobenzylguanidine ([131I]MIBG) in combination with other agents. Eur J Cancer. 2000; 35(8):1171-3. DOI: 10.1016/s0959-8049(99)00114-8. View

13.

Solanki K, Bomanji J, Moyes J, Mather S, Trainer P, Britton K . A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG). Nucl Med Commun. 1992; 13(7):513-21. DOI: 10.1097/00006231-199207000-00006. View

14.

Hoefnagel C, de Kraker J, Valdes Olmos R, VOUTE P . [131I]MIBG as a first line treatment in advanced neuroblastoma. Q J Nucl Med. 1995; 39(4 Suppl 1):61-4. View

15.

Young Jr J, Ries L, Silverberg E, Horm J, Miller R . Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986; 58(2 Suppl):598-602. DOI: 10.1002/1097-0142(19860715)58:2+<598::aid-cncr2820581332>3.0.co;2-c. View

16.

Gelfand M . Meta-iodobenzylguanidine in children. Semin Nucl Med. 1993; 23(3):231-42. DOI: 10.1016/s0001-2998(05)80104-7. View

17.

Bonnin F, Lumbroso J, Tenenbaum F, Hartmann O, Parmentier C . Refining interpretation of MIBG scans in children. J Nucl Med. 1994; 35(5):803-10. View

18.

Parisi M, Greene M, Dykes T, Moraldo T, Sandler E, Hattner R . Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma. Invest Radiol. 1992; 27(10):768-73. DOI: 10.1097/00004424-199210000-00003. View

19.

Gordon I, Peters A, Gutman A, Morony S, Pritchard J . Skeletal assessment in neuroblastoma--the pitfalls of iodine-123-MIBG scans. J Nucl Med. 1990; 31(2):129-34. View

20.

Lumbroso J, Guermazi F, Hartmann O, Coornaert S, Rabarison Y, Leclere J . Meta-iodobenzylguanidine (mIBG) scans in neuroblastoma: sensitivity and specificity, a review of 115 scans. Prog Clin Biol Res. 1988; 271:689-705. View